Latebreakers: CMS announces second round of Medicare DMEPOS competitive bidding program

The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Regulatory officials said additional requirements are needed in order to approve the drug, which is under review for treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

The 2023 AAP Annual Conference will take place in New Orleans from April 20 to 22.

According to a study, patients are frequently prescribed broad-spectrum antibiotics instead of narrowly tailored antibiotics, which would be more optimized to treat them.